Balance Rehabilitation After Hip Fracture Surgery (BRS)

August 1, 2018 updated by: Sang Yoon Lee, Seoul National University Hospital

Effectiveness of the Computerized Balance Rehabilitation After Hip Fracture Surgery

The overall functional gain by balance rehabilitation after hip fracture surgery has not yet been fully investigated. Therefore, clinical studies should be conducted to evaluate the effectiveness of systematic and safe balance rehabilitation in patients after hip fracture. Investigators aim to evaluate the effect of computer-based balance specific exercise on the performance and balance ability of the elderly women who underwent hip fracture surgery. Investigators also investigate the intervention can reduce their fear of falling and coping ability. This study was designed as a prospective, open-label, single-center trial at a tertiary hospital setting. During the 2-week postoperative intervention period, patients will participate in the hospital's exercise program beginning 5-7 days after hip fracture surgery. All participants will follow the computer-based balance specific exercise program. Functional outcomes will be measure periodically for 6 months after surgery.

Study Overview

Status

Unknown

Conditions

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 100 years (OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Elderly female patients (≥ 65 years old) who have undergone surgery for femoral neck, intertrochanteric, or subtrochanteric fracture, regardless of surgery type (internal fixation, bipolar hemiarthroplasty, or total hip arthroplasty)

Exclusion Criteria:

  • 1) hip surgery for infection, arthritis, implant loosening, or avascular necrosis;
  • 2) femoral shaft fracture, acetabular fracture, isolated fracture of the greater or lesser tuberosity, or periprosthetic fracture;
  • 3) pathologic fracture;
  • 4) combined multiple fracture;
  • 5) revision surgery;
  • 6) severe cognitive dysfunction (obey command ≤ 1 step);
  • 7) cannot stand by supporting a fixed walker at 5 days after operation;
  • 8) patients who refuse to participate in a clinical trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Balance exercise group
During the 2-week postoperative intervention period, patients will participate in the hospital's exercise program beginning 5-7 days after HFS. All participants will follow the computer-based balance specific exercise (BSE) program.
Balance specific exercise consists of total 10 days' physical therapy (PT) sessions (twice per day for 60 min) after surgery. It will be conducted with a computed posturographic system for diagnostics of balance and movement skills (Balance Master® System NeuroCom®) designed to objectively quantify balance and postural function of different origin. PT (weight-bearing, strengthening, gait training, aerobic, and functional exercises) was gradually increased based on the patient's functional level. Intensive patient education by multidisciplinary rehabilitation members was also provided.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Berg balance scale
Time Frame: Change from Baseline Berg balance scale at 6 months
Berg balance scale (total score; 0 to 56)
Change from Baseline Berg balance scale at 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Ambulatory Category
Time Frame: Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
Functional Ambulatory Category (categorical score; 0 to 5)
Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
Functional Independence Measure: locomotion
Time Frame: Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
Functional Independence Measure (subscale of locomotion: 1 to 7)
Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
Modified falls efficacy scale
Time Frame: Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
Modified falls efficacy scale (total score: 0 to 140)
Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
Presence of Fear of falling
Time Frame: Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
Fear of falling (yes or no; by simple question "Are you afraid of falling?")
Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
Modified Barthel index
Time Frame: Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
Modified Barthel index (tota; score: 0 to 100)
Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
Short physical performance scale
Time Frame: Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery
Short physical performance scale (total score: 0 to 12)
Before intervention, After 2 weeks' intervention, 3 and 6 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

August 1, 2018

Primary Completion (Anticipated)

December 1, 2019

Study Completion (Anticipated)

December 1, 2019

Study Registration Dates

First Submitted

July 19, 2018

First Submitted That Met QC Criteria

August 1, 2018

First Posted (Actual)

August 7, 2018

Study Record Updates

Last Update Posted (Actual)

August 7, 2018

Last Update Submitted That Met QC Criteria

August 1, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 20-2018-46

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe